About

Connie is an Associate on the healthcare team at F-Prime Capital. She works closely with the Eight Roads Ventures China team to manage F-Prime’s existing and new investment efforts in China. Prior to joining F-Prime Capital, Connie was a Consultant with IQVIA in New York, where she advised biopharmaceutical companies on commercial, development, and portfolio strategy topics.

Connie received her B.S.E. in Bioengineering from the University of Pennsylvania.

  • Geneception is a fully-integrated gene and cell therapy based in Hangzhou and Shanghai, China.  Founded by F-Prime Capital, Eight Roads Ventures China and Lilly Asia Ventures in 2018, Geneception’s mission is to become a preeminent gene and cell therapy company, working to deliver world-class therapeutics for patients in China and globally.